LGP's Principal Activity is the cultivation and production of medicinal cannabis products.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||+162.56%|
|vs ASX 200 (1yr)||+125.33%|
|ASX Rank||987 of 2,556|
|Sector Rank||79 of 177|
Little Green Pharma Ltd (LGP) operates in the medicinal cannabis industry. Medicinal cannabis is defined as cannabis products used under recommendation by a medical professional for a defined medical condition.
No incorporation details available.
|No dividends paid.|
See Upcoming Dividends for all ASX companies.
|Mr Alistair Warren||Company Secretary||Jul 2020|
|Dr Neale William Fong||Non-Executive Director||Nov 2018||
Dr Neale William Fong
Dr Fong has over 35 years in senior leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. He is currently Chair of the Western Australian Government Country Health Service Board, Professor of Healthcare Leadership at Curtin University, Executive Chairman of Bethesda Health Care and a Director of a number of health-related start-up companies. He is an experienced ASX company Director including a former Non-Executive Director of Neurotech International Limited (ASX:NTI) and executive chair of Chrysalis Resources Limited (ASX:CYS). He was formerly Director General of the Western Australian Department of Health and CEO of St John of God Hospital in Perth. Neale was awarded the Centenary Medal in 2011 for services to healthcare by the Australian Government.
|Mr Michael David Lynch-Bell||Non-Executive Chairman,Non-Executive Director||Nov 2018||
Mr Michael David Lynch-Bell
Non-Executive Chairman,Non-Executive Director
Mr Lynch-Bell is an experienced corporate finance executive and consultant. His early Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst & Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re-organisations, transactions, corporate governance as well as IPOs. Michael is a former Chair of the Bureau and current member of UNECE's Expert Group on Resource Measurement and a non-executive Director of Barloworld Limited (JSE:BAW), Senior Independent Director and Remuneration Committee Chair of Gem Diamonds Limited (LSE:GEMD), Audit Committee Chair of Lenta Limited (LSE:LNTA) (MCX:LNTA) and Deputy Chair and Nomination Committee Chair of Kaz Minerals plc (LSE:KAZ).
|Mr Angus McDougall Caithness||Executive Director||Feb 2018||
Mr Angus McDougall Caithness
Mr Caithness is an experienced corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a Non-Executive Director of Lindian Resources Limited (ASX:LIN), CFO of Hunnu Coal (ASX:HUN) and Company Secretary for the IPO of Haranga Resources (ASX:HAR). Following these roles, Angus acted as CFO of Erdenes Tavan Tolgoi, the owner of the coking coal deposit. Angus was previously an Executive Director at EY in London and Australia focusing in initial public offerings of mining companies. Angus is a Harvard Business School alumnus and is currently completing a Master of Science
|Ms Fleta Jennifer Solomon||Managing Director||May 2017||
Ms Fleta Jennifer Solomon
Ms Solomon has 17 years' experience in corporate and consumer health markets. Over ten years, Fleta established, grew and sold one of Australia's providers of workplace health services. She has since been involved in several start-ups including a water treatment technology business and a digital health engagement company based in Singapore.
LGP directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|12/03/21||Neale Fong||Issued||41,413||$0.549||$22,742||Conversion of securities|
|12/03/21||Neale Fong||Exercise||41,413||$0.549||$22,742||Conversion of securities|
|12/03/21||Michael Lynch-Bell||Issued||150,917||$0.70||$105,641||Conversion of securities|
|12/03/21||Michael Lynch-Bell||Exercise||150,917||$0.70||$105,641||Conversion of securities|
|12/03/21||Michael Lynch-Bell||Issued||82,826||$0.549||$45,485||Conversion of securities|
|12/03/21||Michael Lynch-Bell||Exercise||82,826||$0.549||$45,485||Conversion of securities|
|12/03/21||Fleta Solomon||Issued||40,723||$0.549||$22,363||Conversion of securities|
|12/03/21||Fleta Solomon||Exercise||40,723||$0.549||$22,363||Conversion of securities|
|12/03/21||Fleta Solomon||Issued||614,716||$0.70||$430,301||Conversion of securities|
|12/03/21||Fleta Solomon||Exercise||614,716||$0.70||$430,301||Conversion of securities|
|12/03/21||Angus Caithness||Exercise||71,782||$0.549||$39,420||Conversion of securities|
|12/03/21||Angus Caithness||Issued||615,516||$0.70||$430,861||Conversion of securities|
|12/03/21||Angus Caithness||Exercise||615,516||$0.70||$430,861||Conversion of securities|
|12/03/21||Angus Caithness||Issued||71,782||$0.549||$39,420||Conversion of securities|
|17/12/20||Neale Fong||Issued||225,458||$0.59||$133,020||Director remuneration|
|17/12/20||Michael Lynch-Bell||Issued||450,917||$0.59||$266,041||Director remuneration|
|17/12/20||Fleta Solomon||Issued||114,716||$0.59||$67,682||Director remuneration|
|17/12/20||Angus Caithness||Issued||115,516||$0.59||$68,154||Director remuneration|
The current holdings of LGP directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
|Name||Last Notice||Total Shares||Shares Held (%)|
|Fleta Jennifer Solomon||15/02/2021||19,600,000||11.10|
12 month transaction history compiled from ASX announcements.
|Date||Name||Bought||Previous %||New %|
|15-10-20||TIGA Trading Pty Ltd||7,659,010||--||5.70|
12 month transaction history compiled from ASX announcements.
|Date||Name||Sold||Previous %||New %|
|12-03-21||TIGA Trading Pty Ltd||7,659,010||5.70||--|
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.